recurrent fallopian tube cancer
Showing 1 - 11 of 11
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer Trial in Australia, Belgium,
Recruiting
- Recurrent Ovarian Cancer
- +2 more
-
Birmingham, Alabama
- +14 more
Oct 11, 2022
Recurrent Ovarian Cancer, Recurrent Epithelial Cancer of Ovary, Recurrent Epithelial Ovarian Cancer Trial in Durham, Oklahoma
Recruiting
- Recurrent Ovarian Cancer
- +6 more
- Oregovomab
- Niraparib
-
Durham, North Carolina
- +2 more
Jul 26, 2022
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (Niraparib, Dostarlimab)
Not yet recruiting
- Recurrent Ovarian Cancer
- +2 more
- (no location specified)
Jul 26, 2022
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
Recurrent Epithelial Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Peritoneal Cancer Trial in Canada, United States
Active, not recruiting
- Recurrent Epithelial Ovarian Cancer
- +2 more
- DPX-Survivac
- +2 more
-
Palo Alto, California
- +8 more
Jun 16, 2021
Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in
Completed
- Recurrent Fallopian Tube Cancer
- +23 more
- ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 25, 2020
Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in
Completed
- Recurrent Fallopian Tube Cancer
- +2 more
- auranofin
- laboratory biomarker analysis
-
Rochester, MinnesotaMayo Clinic
Jul 31, 2019
Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma, Recurrent Fallopian Tube Cancer Trial in Philadelphia
Withdrawn
- Ovarian Papillary Serous Carcinoma
- +5 more
- metformin hydrochloride
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 18, 2019
Anxiety Disorder, Depression, Fatigue Trial in Columbus (other, procedure, behavioral)
Completed
- Anxiety Disorder
- +19 more
- questionnaire administration
- +5 more
-
Columbus, OhioOhio State University Medical Center
Oct 8, 2015
Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial
Withdrawn
- Recurrent Fallopian Tube Cancer
- +32 more
- ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
- +3 more
- (no location specified)
Dec 17, 2013